Alembic Pharmaceuticals fixes record date for dividend on Jul 29

0 min read     Updated on 13 Jul 2026, 05:41 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Alembic Pharmaceuticals has fixed July 29, 2026, as the record date to determine eligibility for the dividend for the financial year ended March 31, 2026. The dividend payment is scheduled to commence on or from August 6, 2026, subject to approval at the Annual General Meeting on August 5, 2026.

powered bylight_fuzz_icon
45247816

*this image is generated using AI for illustrative purposes only.

Alembic Pharmaceuticals Limited has fixed Wednesday, July 29, 2026, as the record date to determine shareholder eligibility for the payment of dividend for the financial year ended March 31, 2026. The payment of dividend will be made on or from Thursday, August 6, 2026, subject to the approval of shareholders at the Annual General Meeting (AGM). The AGM is scheduled to be held on August 5, 2026.

The intimation was made pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed the record date and payment timeline in a communication to the stock exchanges.

Key Dividend Dates

Sr. No. Particulars Dates
1. Record Date for Dividend July 29, 2026
2. AGM Date August 5, 2026
3. Dividend Payment Date On or from August 6, 2026

Historical Stock Returns for Alembic Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.76%+0.89%+12.73%+4.29%-14.95%-14.79%

What is the expected dividend payout ratio for the financial year 2026?

How might this dividend announcement impact Alembic Pharmaceuticals' stock liquidity around the record date?

What are the company's capital allocation plans for retained earnings post-dividend distribution?

Alembic Pharmaceuticals
View Company Insights
View All News
like15
dislike

Alembic Pharmaceuticals Records ₹34.08 Crore Block Trade on NSE at ₹788.65 Per Share

0 min read     Updated on 30 Jun 2026, 11:27 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Alembic Pharmaceuticals recorded a block trade on the NSE involving approximately 432,102 shares at ₹788.65 per share. The total transaction value stood at ₹34.08 crores, highlighting significant large-investor activity in the stock. Block trades of this magnitude are typically associated with institutional participants executing bulk transactions to limit market impact.

powered bylight_fuzz_icon
44344637

*this image is generated using AI for illustrative purposes only.

Alembic Pharmaceuticals witnessed a notable block trade on the National Stock Exchange (NSE), with approximately 432,102 shares transacted at a price of ₹788.65 per share. The total value of the block trade amounted to ₹34.08 crores, indicating significant large-ticket activity in the stock.

Block Trade Details

The following table summarizes the key parameters of the block trade recorded on the NSE:

Parameter: Details
Exchange: NSE
Number of Shares: ~432,102
Trade Price: ₹788.65 per share
Total Trade Value: ₹34.08 crores

Block trades of this scale typically involve institutional investors, mutual funds, or other large market participants executing bulk transactions outside the regular order book to minimize market impact. The trade in Alembic Pharmaceuticals reflects considerable interest from large investors in the company's stock at the recorded price level.

Historical Stock Returns for Alembic Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.76%+0.89%+12.73%+4.29%-14.95%-14.79%

What are the potential reasons behind the institutional investor's decision to execute this block trade at the current price level?

How might this large transaction influence Alembic Pharmaceuticals' stock price and trading volume in the upcoming sessions?

Could this block trade signal a shift in market sentiment or upcoming strategic developments for the company?

Alembic Pharmaceuticals
View Company Insights
View All News
like20
dislike

More News on Alembic Pharmaceuticals

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-14.95%